Breast cancer is one of the most significant health concerns facing women in the U.S., affecting roughly 1 in 8 women in her lifetime — the American Cancer Society estimates about 321,910 new invasive cases in women and 2,670 in men will be diagnosed in 2026, most often after age 50, though it can occur at any age.^1,2 The causes of breast cancer are complex: age, genetics, reproductive history, hormones, lifestyle, and environmental exposures all play a role, but exactly how normal breast cells turn cancerous is still not fully understood. The National Institute of Environmental Health Sciences (NIEHS) describes it as a disease shaped by interacting genetic, hormonal, and environmental factors.²

That complexity has drawn growing research attention to modifiable environmental exposures — particularly endocrine disruptors, chemicals that interfere with the body's hormonal signaling. Evidence increasingly links these exposures to breast cancer risk, though the degree of risk depends on the chemical, dose, timing, duration, and type of exposure. 

A clear understanding of the current evidence and the remaining uncertainties is essential when considering breast health, environmental exposures, and the potential relationship between hormone-related exposures and cancer risk. 

What Are Endocrine Disruptors? 

Endocrine-disrupting chemicals (EDCs) are natural or human-made substances that interfere with the endocrine system, the hormonal network regulating reproduction, development, metabolism, stress response, and growth. They can mimic, block, or otherwise alter hormone activity, affecting production, transport, receptor activity, or cellular signaling.^3,4

EDCs are not one single class of chemicals; they are a broad group encountered through food, water, air, dust, consumer products, and occupational settings. Examples studied in environmental-health research include bisphenols (like BPA), pesticides, phthalates, PAHs, PFAS, parabens, and certain flame retardants.^3,4

One key distinction is that endocrine activity does not automatically mean a chemical causes cancer. A carcinogen causes cancer; an endocrine disruptor interferes with hormone signaling. Some chemicals have both properties, but the terms aren't interchangeable — a theme worth keeping in mind. 

Why Do Hormones Matter in Breast Cancer? 

Hormones are central to normal breast development and function. Estrogen and progesterone shape breast tissue throughout a person's reproductive years, and hormone signaling plays an established role in the biology and treatment of many breast cancers.^2,5,6

This matters clinically because many breast tumors carry hormone receptors; cells are routinely tested for estrogen receptors (ER) and progesterone receptors (PR), which help clinicians understand tumor biology, estimate prognosis, and decide whether hormone-based treatments make sense.^7,8 This well-established hormone–breast cancer link is exactly why environmental chemicals that interfere with hormone signaling are worth studying. 

The Hormone Connection: How Endocrine Disruptors Affect Hormone Metabolism 

EDCs may influence hormone biology in several ways; production, metabolism, transport, clearance, receptor activity, and downstream signaling have all been studied.^9,10 Some interact with enzymes that make and break down steroid hormones, including cytochrome P450 enzymes, aromatase, and 5a-reductase.^10,11 Since the body constantly produces, converts, and clears hormones, disruptions anywhere along that pipeline could shift signaling. Research has also linked EDC exposure to adrenal and HPA-axis changes, though these relationships are complex to interpret in humans.¹² 

The Breast Cancer Connection: From Hormone Disruption to Risk 

The link between endocrine disruption and breast cancer is an active area of research. Systematic reviews and meta-analyses have found associations between certain EDC exposures, including select pesticides and persistent chemicals, and breast cancer.^13-15 Taken together, observed associations and evidence of plausible biological mechanisms can provide important clues about how these chemicals may influence breast cancer risk. 

Some EDCs can bind hormone receptors, alter hormone metabolism, or influence gene expression and tissue development, mechanisms that may matter most in breast tissue, since the mammary gland goes through major changes during prenatal development, puberty, pregnancy, and menopause.^2,3,4 Researchers use the term “windows of susceptibility” to describe developmental stages when environmental exposures may have different biological effects than they would at other points in life, including during periods of major breast-tissue development. NIEHS and the Breast Cancer and the Environment Research Program (BCERP) have investigated this connection,^2,16 giving biological plausibility to studying EDCs as potential contributors to breast cancer, and a real reason to keep researching modifiable environmental factors. 

Here's what the research says about a few common culprits: 

Bisphenols and Breast Cancer Risk 

Bisphenols, especially bisphenol A (BPA), are widely used in plastics, canned foods, food packaging, and other consumer products, with diet considered a major source of BPA exposure. Laboratory and animal studies suggest BPA can alter estrogen signaling, mammary-gland development, and susceptibility to mammary tumors.^17-21

It is important to note that choosing a product labeled “BPA-free” does not necessarily eliminate exposure to chemicals with estrogenic or other endocrine activity. Some BPA substitutes, including bisphenol S (BPS), bisphenol F (BPF), and bisphenol AF (BPAF), have shown estrogenic activity in laboratory studies, although evidence that these alternatives increase breast cancer risk in humans remains very limited. Current evidence does not establish that typical exposure to BPA or its alternatives causes breast cancer in humans, but their biological effects warrant continued study.^21-23

Pesticides and Breast Cancer Risk 

Pesticides are a broad, diverse category — some have endocrine-disrupting properties, while others do not. Research has linked certain pesticides, including p,p′-DDT/DDE, dieldrin, chlordane, hexachlorocyclohexane (HCH), and heptachlor/heptachlor epoxide, with higher breast cancer risk.^13-15 However, these findings do not mean that all pesticides carry the same risk, or that exposure will affect everyone in the same way. Understanding breast cancer risk requires looking at the specific chemical, level and route of exposure, timing, individual susceptibility, and strength of the available evidence. 

PAHs and Breast Cancer Risk 

Polycyclic aromatic hydrocarbons (PAHs) come from burning fossil fuels, tobacco, wood, and food,  including cigarette smoke and chargrilled meat. They can damage DNA and disrupt estrogen signaling, while animal studies suggest they may interfere with BRCA1 and contribute to hormone-dependent tumors.^24-26 A systematic review and meta-analysis of epidemiologic studies reported that higher PAH exposure was associated with breast cancer. The researchers also found that factors such as smoking history, family history, and genetic differences in how carcinogens are metabolized could influence the observed relationship.²⁷

Phthalates and Breast Cancer Risk 

Phthalates can alter estrogen-related signaling involved in breast carcinogenesis, and laboratory studies suggest chemicals such as DEHP, DBP, and BBP may promote breast-cell growth. However, human studies remain inconsistent, and meta-analyses have not found a clear association between phthalate exposure and breast cancer.^28-30 The biological concern is plausible, but evidence of increased breast cancer risk in humans remains limited. 

What Should We Do About Endocrine Disruptor Exposure? 

Growing research on EDCs and breast cancer does not mean every exposure will cause breast cancer, or that you can avoid every chemical in daily life. A practical approach is to reduce exposure where reasonably possible, through informed cleaner food and drinking-water choices, workplace safety, reducing household dust, and choosing consumer products with fewer known or suspected EDCs, while supporting the body's natural detoxification pathways through lifestyle, diet, targeted nutrients, or other medical care when appropriate. These steps may help support overall health while research continues to clarify how best to reduce the potential effects of EDC exposure.^31-34

The Bottom Line: Endocrine Disruptors, Hormones, and Breast Cancer 

Certain environmental chemicals can disrupt endocrine signaling, and research links some exposures, including pesticides, bisphenols, PAHs, and persistent chemicals, with breast cancer. ^{3, 13–15, 35} It is important to keep in mind that breast cancer results from complex interactions among genetics, biology, hormones, reproductive history, lifestyle, social conditions, and environmental exposures,^2,16 not a single cause.  

Because some environmental factors are modifiable, continued research offers meaningful opportunities for prevention. The goal is to take environmental concerns seriously while keeping prevention, screening, and risk assessment grounded in the best available evidence. 

References 

1. American Cancer Society. Cancer facts & figures 2026 [Internet]. Atlanta (GA): American Cancer Society; 2026 [cited 2026 Sep 10]. Available from: https://www.cancer.org/cancer/types/breast-cancer/about/how-common-is-breast-cancer.html 
2. National Institute of Environmental Health Sciences. Breast cancer [Internet]. Research Triangle Park (NC): National Institute of Environmental Health Sciences; 2026 May 27 [cited 2026 Sep 4]. Available from:  
3. Endocrine Society. Endocrine-disrupting chemicals [Internet]. Washington (DC): Endocrine Society; 2025 Apr 22 [cited 2026 Sep 4]. Available from:  
4. National Institute of Environmental Health Sciences. Endocrine disruptors [Internet]. Research Triangle Park (NC): National Institute of Environmental Health Sciences; 2026 Mar 6 [cited 2026 Sep 4]. Available from:  
5. National Cancer Institute. Reproductive history and cancer risk [Internet]. Bethesda (MD): National Cancer Institute; 2016 Nov 9 [cited 2026 Sep 4]. Available from:  
6. National Cancer Institute. Hormones [Internet]. Bethesda (MD): National Cancer Institute; 2015 Apr 29 [cited 2026 Sep 4]. Available from:  
7. National Cancer Institute. Tests for breast cancer biomarkers [Internet]. Bethesda (MD): National Cancer Institute; 2025 Dec 2 [cited 2026 Sep 4]. Available from:  
8. National Cancer Institute. Hormone receptor positive [Internet]. Bethesda (MD): National Cancer Institute; [cited 2026 Sep 4]. Available from:  
9. Tabb MM, Blumberg B. New modes of action for endocrine-disrupting chemicals. Mol Endocrinol. 2006 Mar;20(3):475-82. doi: 10.1210/me.2004-0513. Epub 2005 Jul 21. PMID: 16037129. 
10. Hampl R, Kubátová J, Stárka L. Steroids and endocrine disruptors--History, recent state of art and open questions. J Steroid Biochem Mol Biol. 2016 Jan;155(Pt B):217-23. doi: 10.1016/j.jsbmb.2014.04.013. Epub 2014 May 9. PMID: 24816231. 
11. Sanderson JT. The steroid hormone biosynthesis pathway as a target for endocrine-disrupting chemicals. Toxicol Sci. 2006 Nov;94(1):3-21. doi: 10.1093/toxsci/kfl051. Epub 2006 Jun 28. PMID: 16807284. 
12. Stüfchen I, Schweizer JROL, Völter F, Nowak E, Braun L, Kocabiyik J, Mederos Y Schnitzler M, Williams TA, Kunz S, Bidlingmaier M, Reincke M. The impact of endocrine disrupting chemicals on adrenal corticosteroids - A systematic review of epidemiological studies. Environ Res. 2025 Jul 1;276:121438. doi: 10.1016/j.envres.2025.121438. Epub 2025 Mar 19. PMID: 40118322. 
13. Wan MLY, Co VA, El-Nezami H. Endocrine disrupting chemicals and breast cancer: a systematic review of epidemiological studies. Crit Rev Food Sci Nutr. 2022;62(24):6549-6576. doi: 10.1080/10408398.2021.1903382. Epub 2021 Apr 5. PMID: 33819127. 
14. Liu H, Sun Y, Ran L, Li J, Shi Y, Mu C, Hao C. Endocrine-disrupting chemicals and breast cancer: a meta-analysis. Front Oncol. 2023 Nov 9;13:1282651. doi: 10.3389/fonc.2023.1282651. PMID: 38023188; PMCID: PMC10665889. 
15. Rocha PRS, Oliveira VD, Vasques CI, Dos Reis PED, Amato AA. Exposure to endocrine disruptors and risk of breast cancer: A systematic review. Crit Rev Oncol Hematol. 2021 May;161:103330. doi: 10.1016/j.critrevonc.2021.103330. Epub 2021 Apr 20. PMID: 33862246. 
16. Interagency Breast Cancer and Environmental Research Coordinating Committee. Breast cancer and the environment: prioritizing prevention [Internet]. Research Triangle Park (NC): National Institute of Environmental Health Sciences; 2013 Feb [cited 2026 Sep 4]. Available from:  
17. National Institute of Environmental Health Sciences. Bisphenol A (BPA) [Internet]. Research Triangle Park (NC): National Institute of Environmental Health Sciences; [cited 2026 Sep 4]. Available from:  
18. Fauconnier MB, Albert C, Tondreau A, Maumy L, Rouzier R, Bonneau C. Bisphénol A et cancer du sein : état des lieux des connaissances et méta-analyse [Bisphenol A and breast cancer: State of knowledge and meta-analysis]. Bull Cancer. 2023 Feb;110(2):151-159. French. doi: 10.1016/j.bulcan.2022.11.011. Epub 2022 Dec 19. PMID: 36543681. 
19. Manzoor MF, Tariq T, Fatima B, Sahar A, Tariq F, Munir S, Khan S, Nawaz Ranjha MMA, Sameen A, Zeng XA, Ibrahim SA. An insight into bisphenol A, food exposure and its adverse effects on health: A review. Front Nutr. 2022 Nov 3;9:1047827. doi: 10.3389/fnut.2022.1047827. PMID: 36407508; PMCID: PMC9671506. 
20. D'Errico S, Baldari S, Di Paolo M, et al. Bisphenols and risk of breast cancer: a narrative review of the impact of diet and bioactive food components. Int J Mol Sci. 2020;21(22):8419. doi:10.3390/ijms21228419. 
21. Pelch KE, Wignall JA, Goldstone AE, Ross PK, Blain RB, Shapiro AJ, et al. A scoping review of the health and toxicological activity of bisphenol A (BPA) structural analogues and functional alternatives. Toxicol In Vitro. 2019;61:104581. doi:10.1016/j.tiv.2019.104581. 
22. Winkler J, Liu P, Phong K, Hinrichs JH, Ataii N, Williams K, et al. Bisphenol A replacement chemicals, BPF and BPS, induce protumorigenic changes in human mammary gland organoid morphology and proteome. Proc Natl Acad Sci U S A. 2022;119(11):e2115308119. doi:10.1073/pnas.2115308119. 
23. Zhao Q, Howard EW, Parris AB, Ma Z, Xing Y, Yang X. Bisphenol AF promotes estrogen receptor-positive breast cancer cell proliferation through amphiregulin-mediated crosstalk with receptor tyrosine kinase signaling. PLoS One. 2019;14(5):e0216469. doi:10.1371/journal.pone.0216469. 
24. Jeffy BD, Chirnomas RB, Romagnolo DF. Epigenetics of breast cancer: polycyclic aromatic hydrocarbons as risk factors. Environ Mol Mutagen. 2002;39(2-3):235-44. doi: 10.1002/em.10051. PMID: 11921194. 
25. Macon MB, Fenton SE. Endocrine disruptors and the breast: early life effects and later life disease. J Mammary Gland Biol Neoplasia. 2013 Mar;18(1):43-61. doi: 10.1007/s10911-013-9275-7. Epub 2013 Feb 17. PMID: 23417729; PMCID: PMC3682794. 
26. Santodonato J. Review of the estrogenic and antiestrogenic activity of polycyclic aromatic hydrocarbons: relationship to carcinogenicity. Chemosphere. 1997 Feb;34(4):835-48. doi: 10.1016/s0045-6535(97)00012-x. PMID: 9569946. 
27. Gamboa-Loira B, López-Carrillo L, Mar-Sánchez Y, Stern D, Cebrián ME. Epidemiologic evidence of exposure to polycyclic aromatic hydrocarbons and breast cancer: A systematic review and meta-analysis. Chemosphere. 2022 Mar;290:133237. doi: 10.1016/j.chemosphere.2021.133237. Epub 2021 Dec 17. PMID: 34929281. 
28. Winz C, Zong WX, Suh N. Endocrine-disrupting compounds and metabolomic reprogramming in breast cancer. J Biochem Mol Toxicol. 2023 Dec;37(12):e23506. doi: 10.1002/jbt.23506. Epub 2023 Aug 20. PMID: 37598318; PMCID: PMC10840637. 
29. Liu G, Cai W, Liu H, Jiang H, Bi Y, Wang H. The Association of Bisphenol A and Phthalates with Risk of Breast Cancer: A Meta-Analysis. Int J Environ Res Public Health. 2021 Mar 1;18(5):2375. doi: 10.3390/ijerph18052375. PMID: 33804363; PMCID: PMC7967730. 
30. Meng M, Yang Y, Song L, Peng J, Li S, Gao Z, Bu Y, Gao J. Association between urinary phthalates and phthalate metabolites and cancer risk: A systematic review and meta-analysis. Heliyon. 2024 Apr 15;10(8):e29684. doi: 10.1016/j.heliyon.2024.e29684. PMID: 38665549; PMCID: PMC11044039. 
31. Hodges RE, Minich DM. Modulation of Metabolic Detoxification Pathways Using Foods and Food-Derived Components: A Scientific Review with Clinical Application. J Nutr Metab. 2015;2015:760689. doi: 10.1155/2015/760689. Epub 2015 Jun 16. PMID: 26167297; PMCID: PMC4488002. 
32. Corbett GA, Lee S, Woodruff TJ, Hanson M, Hod M, Charlesworth AM, Giudice L, Conry J, McAuliffe FM; International Federation of Gynecology and Obstetrics (FIGO) Committee on Impact of Pregnancy on Long-term Health and the FIGO Committee on Climate Change and Toxic Environmental Exposures. Nutritional interventions to ameliorate the effect of endocrine disruptors on human reproductive health: A semi-structured review from FIGO. Int J Gynaecol Obstet. 2022 Jun;157(3):489-501. doi: 10.1002/ijgo.14126. Epub 2022 Feb 23. PMID: 35122246; PMCID: PMC9305939. 
33. Genuis SJ, Lane K, Birkholz D. Human Elimination of Organochlorine Pesticides: Blood, Urine, and Sweat Study. Biomed Res Int. 2016;2016:1624643. doi: 10.1155/2016/1624643. Epub 2016 Oct 5. PMID: 27800487; PMCID: PMC5069380. 
34. Kovacs K, Bodis J, Vass RA. Microplastics, Endocrine Disruptors, and Oxidative Stress: Mechanisms and Health Implications. Int J Mol Sci. 2025 Dec 30;27(1):399. doi: 10.3390/ijms27010399. PMID: 41516273; PMCID: PMC12785609. 
35. National Institute of Environmental Health Sciences. Endocrine disruptors [Internet]. Research Triangle Park (NC): National Institute of Environmental Health Sciences; [cited 2026 Sep 4]. Available from: